Advances in Cell and Gene Therapy · 2021 · 36 citations · 16 references
Life SciencesBiologyMolecular BiologyGenomicsMolecular VirologyVirologyRna InterferenceViral GeneticsViral Genome OrganizationViral InfectionsViral Rna BiologyVirus Genome OrganizationAntiviral Rna InterferenceDuplex StabilityMolecular Docking AnalysisRna Duplex StabilityRna Virus BiologySmall Interfering Ribonucleic Acids (Sirnas)Subgenomic Messenger RnaViral Replication Control
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is a retrovirus having genome size of around 30 kb. Its genome contains a highly conserved leader sequence at its 5' end, which is added to all subgenomic mRNAs at their 5' terminus by a discontinuous transcription mechanism and regulates their translation. Targeting the leader sequence by RNA interference can be an effective approach to inhibit the viral replication. In the present study an in-silico prediction of highly effective siRNAs was performed to target the leader sequence using the online software siDirect version 2.0. Low seed-duplex stability, exact complementarity with target, at least three mismatches with any off-target and least number of off-targets, were considered as effective criteria for highly specific siRNA. Further validation of siRNA affinity for the target was accomplished by molecular docking by HNADOCK online server. Our results revealed four potential siRNAs, of which siRNA having guide strand sequence 5'GUUUAGAGAACAGAUCUACAA3' met almost all specificity criteria with no off-targets for guide strand. Molecular docking of all predicted siRNAs (guide strand) with the target leader sequence depicted highest binding score of -327.45 for above-mentioned siRNA. Furthermore, molecular docking of the passenger strand of the best candidate with off-target sequences gave significantly low binding scores. Hence, 5'GUUUAGAGAACAGAUCUACAA3' siRNA possess great potential to silence the leader sequence of SARS-CoV-2 with least off-target effect. Present study provides great scope for development of gene therapy against the prevailing COVID-19 disease, thus further research in this concern is urgently demanded.
16
The Architecture of SARS-CoV-2 Transcriptome
Dong-Wan Kim, Joo-Yeon Lee, Jeong‐Sun Yang et al. · Cell · 2020 · 2.4K citations · Full text
Structure of replicating SARS-CoV-2 polymerase
Hauke S. Hillen, Goran Kokić, Lucas Farnung et al. · Nature · 2020 · 844 citations · Full text
The coding capacity of SARS-CoV-2
Yaara Finkel, Orel Mizrahi, Aharon Nachshon et al. · Nature · 2020 · 668 citations · Full text
Inhibition of genes expression of SARS coronavirus by synthetic small interfering RNAs
Yi Shi, Dehua Yang, Jie Xiong et al. · Cell Research · 2005 · 416 citations · Full text